| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/27/2000 | WO1999051220A9 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19845286A1 New carrier material coated with specific antibodies, used to remove tumor necrosis factor and other disease-associated compounds from blood, for treating arthritis or pyelonephritis |
| 04/27/2000 | CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation |
| 04/27/2000 | CA2347204A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 04/27/2000 | CA2347083A1 Methods of administering adenoviral vectors |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting |
| 04/27/2000 | CA2346879A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | CA2346799A1 Delivery system for porcine somatotropin |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2346325A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 04/27/2000 | CA2345767A1 Therapy for improving cognition |
| 04/26/2000 | EP0995755A1 Prodrugs of Thrombin inhibitors |
| 04/26/2000 | EP0995751A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995750A1 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 04/26/2000 | EP0995743A1 Derivatives of dihydro- and tetrahydrochinoline as a medicinal antioxydans |
| 04/26/2000 | EP0995446A2 Antithrombin III-beta containing medical preparation |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0995439A1 Use of indazole derivatives in the manufacture of a medicament for treating congestive heart failure |
| 04/26/2000 | EP0995436A2 Ligands for sigma receptors and their therapeutical applications |
| 04/26/2000 | EP0994904A2 AMINO ACID SEQUENCES FOR THERAPEUTICAL AND PROPHYLACTIC APPLICATIONS TO DISEASES DUE TO $i(CLOSTRIDIUM DIFFICILE) TOXINS |
| 04/26/2000 | EP0994900A1 Semaphorin receptors |
| 04/26/2000 | EP0994896A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/26/2000 | EP0994880A1 Crystalline macrolides and process for their preparation |
| 04/26/2000 | EP0994877A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 04/26/2000 | EP0994876A1 Quaternary ammonium compounds as tachykinin antagonists |
| 04/26/2000 | EP0994873A1 Substituted 1h-pyridinyl-2-ones as gaba a?alpha 2/3 ligands |
| 04/26/2000 | EP0994870A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 04/26/2000 | EP0994869A1 5-(2-ETHYL-2$i(H)-TETRAZOL-5-Y1)-1-METHYL-1,2,3,6-TETRAHYDROPYRIDINE MALEATE |
| 04/26/2000 | EP0994867A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 04/26/2000 | EP0994866A1 5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives |
| 04/26/2000 | EP0994865A1 Triazole compounds and the use thereof as dopamine-d 3?-ligands |
| 04/26/2000 | EP0994861A1 NEW $g(b)-AMINO AND $g(b)-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 04/26/2000 | EP0994860A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 04/26/2000 | EP0994859A1 Compounds |
| 04/26/2000 | EP0994858A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/26/2000 | EP0994857A1 (1h-imidazol-4-yl)piperidine derivatives, preparation and application in therapy |
| 04/26/2000 | EP0994856A1 Inhibitors of farnesyl protein transferase |
| 04/26/2000 | EP0994853A2 Compounds and methods for the inhibition of the expression of vcam-1 |
| 04/26/2000 | EP0994720A1 Use of bromelain in the manufacture of a medicament for enhancement of intestinal permeability |
| 04/26/2000 | EP0994719A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 04/26/2000 | EP0994712A1 Inhibitors of neutrophil mediated oxidant production |
| 04/26/2000 | EP0994711A1 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and rnal function |
| 04/26/2000 | EP0994710A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 04/26/2000 | EP0994709A1 Calcium blockers to treat proliferative vitreoretinopathy |
| 04/26/2000 | EP0994705A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 04/26/2000 | EP0994702A2 Medicament comprising adenosine |
| 04/26/2000 | EP0994696A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
| 04/26/2000 | EP0832127B1 Synthetic peptides and pharmaceutical compositions comprising them |
| 04/26/2000 | EP0777671B1 Spiro-azabicyclic compounds useful in therapy |
| 04/26/2000 | EP0771209A4 Novel peptides |
| 04/26/2000 | EP0738269B1 Piperidine derivatives with paf antagonist activity |
| 04/26/2000 | EP0680469B1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same |
| 04/26/2000 | EP0680318B1 Method for increasing the efficiency of feed conversion in animals |
| 04/26/2000 | EP0670826B1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 04/26/2000 | EP0554381B2 Use of protective agents against reactive oxygen species |
| 04/26/2000 | CN1251589A Substituted triazolo-pyridazine derivatives as ligands for GABA receptors |
| 04/26/2000 | CN1251579A Compound and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 04/26/2000 | CN1251569A Noval compounds, their use and preparation |
| 04/26/2000 | CN1251531A Treatment of inner ear hair cells |
| 04/26/2000 | CN1251524A Pharmaceutical composition for oral administration of N-piperidino-3-phrazolecarboxamide derivative, its salts and their solvates |
| 04/26/2000 | CN1251520A Use of sodium channel blocker in manfacture of medicament for preventing optic nerve degeneration associated with glaucoma |
| 04/26/2000 | CN1251309A Method for preparing medicinal absinthium extracted liquor and electro-moxibustion apparatus using said extracted liquor |
| 04/26/2000 | CN1251300A Traditional Chinese medicine compounded preparation for preventing and treating rabies and preparation method thereof |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/26/2000 | CN1051767C Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 04/26/2000 | CN1051766C Angiotension II antagonist imidazole derivatives, their preparation and therapeutic use |
| 04/26/2000 | CN1051758C Anti-androgenic cyclo and bicycle alkenes |
| 04/26/2000 | CN1051715C Iodine-containing seaweed health-care preparation and preparing method thereof |
| 04/26/2000 | CN1051704C Composition containing retionic acids and tocopherol |
| 04/25/2000 | US6054590 Imidazolone anorectic agents: II. phenyl derivatives |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054491 Administering one type of xanthophylles in the feed to mammals |
| 04/25/2000 | US6054485 Eye treatments using synthetic thyroid hormone compositions |
| 04/25/2000 | US6054474 Activating opioid receptors |
| 04/25/2000 | US6054470 Src family SH2 domain inhibitors |
| 04/25/2000 | US6054463 Methods for treating dermatitis using descarboethoxyloratadine |
| 04/25/2000 | US6054457 Benzamide derivatives and their use as vasopressin antagonists |
| 04/25/2000 | US6054452 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 04/25/2000 | US6054446 17-substituted-17-desoxy-1,3,5-estratrienes. |
| 04/25/2000 | US6054443 Exocellular polysaccharide produced by Streptococcus thermophilus |
| 04/25/2000 | US6054436 Regulated apoptosis |
| 04/25/2000 | US6054430 Substantially free of species having a molecular weight of over 40 kilodaltons; trifluoroacetyl copolymer-1 treated with hbr. |
| 04/25/2000 | US6054428 Allow the toxic effects of cytotoxic drugs, e.g., cyclosporin, when used at high dosages or over prolonged times to be alleviated or even suppressed. |
| 04/25/2000 | US6054312 Receptor-mediated gene delivery using bacteriophage vectors |
| 04/25/2000 | US6054308 Arginase II |
| 04/25/2000 | US6054293 Polypeptide involved in chemotatic response; screening for modulator proteins involved in nerve cell migration |
| 04/25/2000 | US6054129 Flavor-improved extract from Cassia mimosoides L. var. nomame Makino and method of preparing the same |
| 04/25/2000 | CA2045453C Condensed heterocyclic compound and psychopharmaceutical composition containing same |
| 04/23/2000 | CA2287562A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 04/21/2000 | CA2287139A1 Method for treating congestive heart failure |
| 04/21/2000 | CA2287122A1 Treatment of bph with cgmp elevators |
| 04/20/2000 | WO2000022146A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022129A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | WO2000022125A2 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022117A1 Tumor protein |